Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Aardvark Therapeutics, Inc.

Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics to Present at Upcoming Investor Conferences in November
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics to Present Data on Pipeline Programs at Upcoming ObesityWeek
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics Announces FDA Alignment on Protocol Amendment Expanding Phase 3 HERO Trial Population for Prader-Willi Syndrome
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics to Present at the Stifel 2025 Virtual Cardiometabolic Forum
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics to Present at Upcoming Investor Conferences in September
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics Reports Second Quarter 2025 Financial Results and Provides Pipeline and Business Updates
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics Announces ARD-201 Preclinical Obesity Data Showing Significant Weight Loss as a Monotherapy, Enhancement of GLP-1RA Therapy in Combination, and Effective Maintenance Following Discontinuation of GLP-1RA Therapy
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics to Join Prader-Willi Syndrome Community at the 2025 United in Hope Conference
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics to Present at Upcoming Investor Conferences in May
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Tickers AARD
Aardvark Therapeutics Announces Pricing of Initial Public Offering
From Aardvark Therapeutics, Inc.
Via GlobeNewswire
Aardvark Therapeutics Appoints Renowned Biopharma Leaders Roy D. Baynes and Susan E. Graf to its Board of Directors
From Aardvark Therapeutics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback